Citation: C. Meier et al., Synthesis, hydrolysis and anti-EBV activity of a series of 3 '-modified cycloSal-BVDUMP pronucleotides, NUCLEOS NUC, 20(4-7), 2001, pp. 307-314
Citation: C. Meier et al., cycloSaligenyl-5-[(E)-2-bromovinyl]2 '-deoxyuridine monophosphate (cycloSal-BVDUMP) pronucleotides active against Epstein-Barr virus, CHEMBIOCHEM, 2(4), 2001, pp. 283-285
Authors:
Meerbach, A
Gruhn, B
Egerer, R
Reischl, U
Zintl, F
Wutzler, P
Citation: A. Meerbach et al., Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases, J MED VIROL, 65(2), 2001, pp. 348-357
Authors:
Meerbach, A
Klocking, R
Meier, C
Lomp, A
Helbig, B
Wutzler, P
Citation: A. Meerbach et al., Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV, ANTIVIR RES, 45(1), 2000, pp. 69-77
Authors:
Gruhn, B
Meerbach, A
Egerer, R
Mentzel, HJ
Hafer, R
Ringelmann, F
Sauer, M
Hermann, J
Zintl, F
Citation: B. Gruhn et al., Successful treatment of Epstein-Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation, BONE MAR TR, 24(12), 1999, pp. 1355-1358